Cancer Patients More Likely to Die From Early Omicron Variants of SARS-CoV-2
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Research documents both direct and indirect effects of the COVID-19 pandemic on kidney health.
Hospitalized and nonhospitalized patients with COVID-19 more likely to develop persistent HTN than those with influenza
Four known cases of the variant, dubbed BA.2.86, have so far been identified worldwide, including the case in Michigan
Differences between the dialysis and nondialysis population were most pronounced during the first Omicron wave, investigators reported.
mRNA-1273 vaccine also tied to greater protection against COVID-19 in older adults
EG.5 is one of several closely related omicron subvariants that have been competing for dominance in recent months
The Office of Long COVID Research and Practice will lead the U.S. response to long COVID, which includes trials that have already been launched
Those whose access to health care was disrupted during COVID-19 have an increased risk for preventable admission